Clinical Trials

  • REBIRTH - Study of Bromocriptine in Women with Peripartum Cardiomyopathy (PPCM)

    Principal Investigator:

    Jennifer H Haythe, MD
    We are doing this study to test the use of a drug called bromocriptine for women with a condition called Peripartum cardiomyopathy (PPCM). The study will look at how the heart muscle improves in women taking bromocriptine compared to a group of women given a placebo or inactive pill.

  • REBIRTH - Study of Bromocriptine in Women with Peripartum Cardiomyopathy (PPCM)

    Principal Investigator:

    Jennifer H Haythe, MD
    We are doing this study to test the use of a drug called bromocriptine for women with a condition called Peripartum cardiomyopathy (PPCM). The study will look at how the heart muscle improves in women taking bromocriptine compared to a group of women given a placebo or inactive pill.

  • Research Goes Red Sleep and Psychosocial Well-being Study

    Principal Investigator:

    Brooke Aggarwal, EdD, MS, FAHA
    Women ages 40-65 years may be eligible to participate in a survey about their sleep patterns, stress, and risk factors for heart disease. If you are interested or would like more information, please email us at researchgoesredsurvey@gmail.com .

  • The BREAK II Study: Breaking up Prolonged Inactivity to Improve Cardiometabolic Health

    Principal Investigator:

    Keith Diaz, PhD
    U.S. Adults spend on average 11 to 12 hours a day sitting. Daily sedentary behavior is strongly associated with the risk of heart disease. The purpose of the BREAK II research study is to answer two questions: (1) How frequently should periods of prolonged sedentary time be interrupted? and (2) What is the appropriate duration or length of time of these breaks in sedentary time? If you are 18 years old or older, have a limited or no history of chronic diseases, have no physical disability preventing ability to walk, and are a non-smoker you may be eligible for this study. Participants will...

  • The MAVERIC Trial

    Principal Investigator:

    Dor Lotan, MD
    The main purpose of the study is to evaluate if treatment with CardioRX will prevent pericarditis recurrences after the therapy with IL-1 blocker (medication to reduce inflammation) has been stopped. You are being asked to join the study because you have recurrent pericarditis. Pericarditis is inflammation of the percardium (double layer sac that surrounds the heart). The pericardium allows your heart to move freely with each heartbeat. Recurrent pericarditis is an episode of pericarditis that occurs after a symptom-free period of more than 4 weeks after the last episode. CardioRX is the...

Pages

Back to top